These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 19295311
1. A matched cohort pharmacoepidemiological analysis of steroid free immunosuppression in renal transplantation. Barraclough KA, Landsberg DN, Shapiro RJ, Gill JS, Li G, Balshaw RF, Chailimpamontree W, Keown PA, Genome Canada Biomarkers in Transplantation Group. Transplantation; 2009 Mar 15; 87(5):672-80. PubMed ID: 19295311 [Abstract] [Full Text] [Related]
4. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R. Pediatr Transplant; 2005 Aug 27; 9(4):498-503. PubMed ID: 16048603 [Abstract] [Full Text] [Related]
5. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I. Transplantation; 2007 Mar 15; 83(5):600-6. PubMed ID: 17353781 [Abstract] [Full Text] [Related]
7. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C. Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487 [Abstract] [Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL, Jin XB, Li XT, Wang HW, Lü JJ. Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748 [Abstract] [Full Text] [Related]
9. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D. Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260 [Abstract] [Full Text] [Related]
11. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine. Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C. Transplant Proc; 2005 Mar 15; 37(2):788-90. PubMed ID: 15848532 [Abstract] [Full Text] [Related]
12. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation. Kim MS, Kim HJ, Kim SI, Ahn HJ, Ju MK, Kim HJ, Jeon KO, Kim YS. Transplantation; 2006 Dec 27; 82(12):1602-5. PubMed ID: 17198243 [Abstract] [Full Text] [Related]
13. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Opelz G, Döhler B, Collaborative Transplant Study. Transplantation; 2009 Mar 27; 87(6):795-802. PubMed ID: 19300179 [Abstract] [Full Text] [Related]
14. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation. Walker JK, Alloway RR, Roy-Chaudhury P, Mogilishetty G, Cardi MA, Weimert NA, Rike AH, First MR, Woodle ES. Transplantation; 2009 Feb 15; 87(3):408-14. PubMed ID: 19202447 [Abstract] [Full Text] [Related]
15. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals. Filipe R, Mota A, Alves R, Bastos C, Macário F, Figueiredo A, Roseiro A, Parada B, Sá H, Nunes P, Bastos M. Transplant Proc; 2009 Apr 15; 41(3):843-5. PubMed ID: 19376367 [Abstract] [Full Text] [Related]
18. Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis. Kolonko A, Pinocy-Mańdok J, Kocierz M, Kujawa-Szewieczek A, Chudek J, Malyszko J, Malyszko JS, Myśliwiec M, Wiecek A. Transplant Proc; 2009 Oct 15; 41(8):3046-51. PubMed ID: 19857673 [Abstract] [Full Text] [Related]
19. Experience from an active preemptive kidney transplantation program--809 cases revisited. Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A. Transplantation; 2009 Sep 15; 88(5):672-7. PubMed ID: 19741464 [Abstract] [Full Text] [Related]
20. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group. Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]